波士頓科學獲得FDA批准，擴大了對Ingevity™+起搏導線的適應症，包括對左束支區傳導

快訊 · 09/17 19:00

Boston Scientific Receives FDA Approval for Expanded Indication of Ingevity™+ Pacing Leads to Include Conduction System Pacing of the Left Bundle Branch Area

波士頓科學獲得FDA批准，擴大了對Ingevity™+起搏導線的適應症，包括對左束支區傳導系統起搏。